Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolismBin Li, Haitao Liu|Acta Pharmaceutica Sinica B|2024Cited by 33